Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation-Reference-Cited by-同舟云学术

Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation

Published:2013-03 Issue:4 Volume:49 Page:826-834
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Kim Beom Kyung,Kim Kyung Ah,Park Jun Yong,Ahn Sang Hoon,Chon Chae Yoon,Han Kwang-Hyub,Kim Seung Up,Kim Myeong-Jin

Funder

Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference28 articles.

1. Reporting results of cancer treatment;Miller;Cancer,1981

2. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada;Therasse;J Natl Cancer Inst,2000

3. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver;Bruix;J Hepatol,2001

4. EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization;Gillmore;J Hepatol,2011

5. Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic–pathologic correlation;Riaz;J Hepatol,2011

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interpretation of the updates of the chinese guidelines for the diagnosis and treatment of primary liver cancer (CNLC-2024 Edition);Hepatoma Research;2024-07-17

2. An efficient approximate analytical technique for the fractional model describing the solid tumor invasion;Frontiers in Physics;2024-07-04

3. Watch-and-Wait strategy vs. resection in patients with radiologic complete response after conversion therapy for initially unresectable hepatocellular carcinoma：a propensity score-matching comparative study;International Journal of Surgery;2024-02-08

4. Treatment response assessment to chemotherapy with bevacizumab for colorectal liver metastasis by contrast-enhanced ultrasound;Quantitative Imaging in Medicine and Surgery;2024-01

5. Comparison of MRI-based response criteria and radiomics for the prediction of early response to transarterial radioembolization in patients with hepatocellular carcinoma;Diagnostic and Interventional Imaging;2022-07